City-level collection of power, a number of drug prices will drop!

"
Pharmaceutical Network Market Analysis" Recently, Jinhua City, Zhejiang Province, the Health Insurance Bureau issued "on the development of Jinhua City, the second batch of drug belt procurement announcement", has formed anti-infective raw research drugs, anti-infection non-original research drugs and traditional Chinese medicine and other three preliminary catalog, a total of 274 product regulations to carry out band procurementFrom the variety type, mainly divided into antibacterial drugs, traditional Chinese medicine two categories, of which antibacterial drugs are broken down into non-primary research, original research varieties, Traditional Chinese medicine is divided into non-low-cost drugs and low-cost drugs, many large varieties in the columnspecifically, Jinhua City's second batch of tape procurement involved: 70 non-original antimicrobial drugs, including injection of alosillin sodium, amoxicillin kravico-potassium capsules, injection of cephalosporinssin, hydrochloric acid klinmycin injection, injection of merobinan, etc.; Sodium pindicateazole, injectable amine pernsiatin, etc.; 147 traditional Chinese medicines (excluding low-cost drugs) and 33 traditional Chinese medicines (including low-cost drugs), including compound fishy herb, oxan yellow on-the-capsule, ginseng injection, strong sein, bailidos, six-flavored yellow pills, and aniresin fact, Jinhua City to carry out the second batch of shipment procurement has long been a precursor, because it has been very active in the volume procurementAs early as the end of last year, Jinhua City has issued the "Jinhua City Drug Supplies Belt Collection Of The Purchase Of Drug Tape Stakes Committee Regulations on drug tape volume procurement", on cephalosporine sodium, cephalosporine, omeprazole sodium, acapo sugar, Tejigio, amoxicillin, hydrochloric acid metformin, sandatin, meracepinan, ammonia chlorine equal 22 commonly used antibacterial drugs, cardiovascular drugsit is understood that in the first batch of volume procurement, Jinhua City requires that pharmaceutical companies quote to the current Zhejiang Province medical insurance payment standards, the reduction must not be less than 10%From the results, Jinhua City successfully completed the goalThe first batch of shipments decreased by an average of 28 per cent, while the number of drugs per single was reduced by 73.6 per centin general, in the national organization of the volume of procurement, some provinces began to carry out local band procurement background, Jinhua City, the amount of procurement groping, from the municipal level, can be said to be in frontThe industry believes that the second batch of jinhua city to carry out the purchase of drug belt volume, on the basis of the first batch of tape procurement made a targeted adjustment, and the price reduction made separate provisions, the price reduction of the selected drugs will also be very substantial, benefiting more patientsat present, in addition to Jinhua City, Zhejiang Province, Shandong Yantai, Shandong Texas, Fujian Sanming, Hubei Wuhan and other cities have also launched their own municipal collectionAt the same time, Hunan, Hebei, Jiangxi, Shandong, Shanxi, Qinghai and other provinces are also carrying out provincial harvestingIt is not difficult to see that different levels of collection are nesting synthesis force, and will act on a large number of drug pricesin addition, earlier industry sources show that the third batch of collection of drug catalog statistics as of the end of June 2020, if the progress is smooth, is expected to start in July, which will be a very big challenge for pharmaceutical companies Industry experts analysis that the future of the country, provinces, cities will be in three levels of drugs, supplies normal implementation of the volume of procurement, drug prices or will usher in a new round of downward adjustment.